2004 Fiscal Year Final Research Report Summary
The intrauterine treatment of congenital diaphragmatic hernia
| Project/Area Number |
15591762
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Obstetrics and gynecology
|
|---|
| Research Institution | Nagasaki University |
|---|
Principal Investigator |
YOSHIMURA Shuichiro Nagasaki University, Hospital of Medicine and Dentistry, lecturer, 医学部・歯学部附属病院, 講師 (00274663)
|
|---|
| Project Period (FY) |
2003 – 2004
|
| Keywords | lung hypoplasia / Vitamin A / congenital diaphragmatic hernia / lung maturation / lung surfactant / nitrofen / rat / lung / body weight ratio |
|---|
| Research Abstract |
ABSTRACT
Congenital diaphragmatic hernia (CDH) is a major cause of refractory respiratory failure in the newborn. Pulmonary hypoplasia often limits survival. Vitamin A (Vit A) is an important signal for lung growth. We hypothesized that antenatal treatment with Vit A would stimulate lung growth and decrease mortality in experimental CDH induced in rats by ingestion of the herbicide nitrofen (2,4-dichlorophenyl-p-nitrophenyl ether). Nitrofen was administered to pregnant rats on day 12 of gestation (term 22 days). Rats were assigned to five groups : three groups received one dose of oral antenatal Vit A (15,000 IU) before (day 10), concomitant with (day 12), or after (day 14) nitrofen administration ; one group received only nitrofen ; and a control group received vehicle (olive oil). The incidence of CDH was markedly lower in all groups receiving Vit A (day 10,19.6% ; day 12,15.3% ; and day 14,21.3%) compared with the nitrofen-treated group (63% ; P<0.05). Lung-to-body weight ratio and radial saccular count were significantly increased by Vit A. Antenatal treatment with Vit A lowers the incidence and severity of experimental CDH and increases lung growth and maturation.
|
